TMO

2024Q1BMO

Thermo Fisher Scientific Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2024-04-24 · Fiscal end 2024-03-31 · Features as of 2024-04-23

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS4.71
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.5%
IV front—
P/C full—
P/C front—
Features as of2024-04-23

Run-up

Close—
Ret 5d+3.6%
Ret 10d-2.5%
Ret 20d+0.2%
Ret 30d-4.1%

Post-Earnings Data

Results & reaction

Print

Actual EPS
5.11Beat
Estimated EPS4.71
Actual revenue
10.3B
Surprise %+8.5%
Beat / missBeat
Beat streak 43
Beat streak 83

Reaction

1-day stock reaction-0.1%
Implied vs actual

Implied 1.5%Actual 0.6%

Gap reaction+0.6%
Day result+0.5%
Next-day upNo
Realized / IV0.39×

Post tape

Post 5d-0.4%
Post 10d-0.6%
Post volume2.0M
Vol ×10d1.33×
Vol ×20d1.49×
Post range3.7%